DLP-160
Naltrexone 1-Year Formulation
Delpor’s DLP-160 is a 1-Year Sustained Release Naltrexone Implant for the prevention of relapse to opioid dependence. The product is using Delpor’s ProzorTM technology and the medication is released from Delpor’s subcutaneous implant device. The system enables zero order release kinetics and it is expected to maintain therapeutic levels of Naltrexone in human plasma for potentially as long as one year.
